1. Home
  2. HWC vs APGE Comparison

HWC vs APGE Comparison

Compare HWC & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hancock Whitney Corporation

HWC

Hancock Whitney Corporation

HOLD

Current Price

$70.79

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$69.84

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWC
APGE
Founded
1883
2022
Country
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HWC
APGE
Price
$70.79
$69.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$75.71
$103.33
AVG Volume (30 Days)
895.7K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.34
N/A
Revenue Next Year
$4.36
N/A
P/E Ratio
$12.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$43.90
$26.20
52 Week High
$75.43
$84.56

Technical Indicators

Market Signals
Indicator
HWC
APGE
Relative Strength Index (RSI) 55.84 49.97
Support Level $69.40 $60.35
Resistance Level $75.43 $71.18
Average True Range (ATR) 1.97 4.34
MACD -0.23 0.34
Stochastic Oscillator 46.55 72.57

Price Performance

Historical Comparison
HWC
APGE

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: